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Accumulation of artemisinin trioxane derivatives within neutral
lipids of Plasmodium falciparum malaria parasites is
endoperoxide-dependent
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Posner2, and Roland A. Cooper1,*
1Department of Biological Sciences, Old Dominion University, Norfolk, VA 23529
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Abstract
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The antimalarial trioxanes, exemplified by the naturally occurring sesquiterpene lactone artemisinin
and its semi-synthetic derivatives, contain an endoperoxide pharmacophore that lends tremendous
potency against Plasmodium parasites. Despite decades of research, their mechanism of action
remains unresolved. A leading model of anti-plasmodial activity hypothesizes that iron-mediated
cleavage of the endoperoxide bridge generates cytotoxic drug metabolites capable of damaging
cellular macromolecules. To probe the malarial targets of the endoperoxide drugs, we studied the
distribution of fluorescent dansyl trioxane derivatives in living, intraerythrocytic-stage P.
falciparum parasites using microscopic imaging. The fluorescent trioxanes rapidly accumulated in
parasitized erythrocytes, localizing within digestive vacuole-associated neutral lipid bodies of
trophozoites and schizonts, and surrounding the developing merozoite membranes. Artemisinin pretreatment significantly reduced fluorescent labeling of neutral lipid bodies, while iron chelation
increased non-specific cytoplasmic localization. To further explore the effects of endoperoxides on
cellular lipids, we used an oxidation-sensitive BODIPY lipid probe to show the presence of
artemisinin-induced peroxyl radicals in parasite membranes. Lipid extracts from artemisinin-exposed
parasites contained increased amounts of free fatty acids and a novel cholesteryl ester. The cellular
accumulation patterns and effects on lipids were entirely endoperoxide-dependent, as inactive
dioxolane analogs lacking the endoperoxide moiety failed to label neutral lipid bodies or induce
oxidative membrane damage. In the parasite digestive vacuole, neutral lipids closely associate with
heme and promote hemozoin formation. We propose that the trioxane artemisinin and its derivatives
are activated by heme-iron within the neutral lipid environment where they initiate oxidation
reactions that damage parasite membranes.
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The control of malaria continues to be a global challenge due to the proliferation of multi-drug
resistant Plasmodium falciparum parasites [1]. Derivatives of artemisinin (ART), a
sesquiterpene lactone endoperoxide isolated from the herb Artemisia annua, are now widely
used in the treatment of falciparum malaria. ART-based combination therapies (ACTs) have
proven efficacious against multi-drug resistant parasites and are now employed by more than
60 countries following World Health Organization recommendations [2]. Despite the extensive
use of ACTs and development of new analogs, the specific molecular targets of the
endoperoxides within P. falciparum remain poorly defined.
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The potency of ART (Fig. 1, 1) depends on a unique 1,2,4-trioxane structure that contains an
endoperoxide bridge; deoxy derivatives lacking a peroxidic bond have no significant
antiparasitic activity [3]. Owing to the ability of ferrous iron to cleave organic peroxides into
reactive free radicals [4], it was proposed that the endoperoxide bridge of ART is activated by
cellular ferrous iron, forming free radical ART metabolites that damage critical cellular
macromolecules [5,6]. Supporting the importance of iron-catalyzed activation are studies
showing that iron chelation attenuates the potency of ART and related endoperoxides towards
Plasmodium [7,8]. One source of cellular iron thought to catalyze peroxide opening is reduced
heme (ferriprotoporphyrin IX), following which heme itself can become a target of alkylation
[9]. From studies with a variety of antimalarial endoperoxides, there is growing evidence that
heme alkylation is an important indicator of drug activity [10-13]. Heme-ART adducts are
found in the spleen and urine of malaria-infected mice treated with therapeutically relevant
doses of ART [14,15]. The parasite digestive vacuole (DV) is rich in heme due to proteolytic
digestion of host hemoglobin [16], possibly explaining the high specific activity of ART against
the parasite as opposed to normal mammalian cells [17]. Heme-catalyzed activation and
alkylation is consistent with the detection of [14C]-ART and [3H]-dihydroART within the DV
[18]. Additionally, one of the earliest physiological changes induced by the endoperoxides is
disruption of the integrity of the DV membrane [19].
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The precise molecular targets of antimalarial endoperoxides remain a topic of considerable
debate [8,20,21]. Metabolites of ART can alkylate proteins in P. falciparum, including a
translationally controlled tumor protein homolog [22]. A recently proposed target of ART is
the P. falciparum sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) homolog, PfATP6
[23]. The sesquiterpene lactone compound thapsigargin and ART competitively inhibit
PfATP6 activity when expressed in Xenopus oocytes. However, the antimalarial contribution
of specific protein binding by ART metabolites remains an open question. Field studies of
SERCA have proven inconsistent; point mutations in the pfatp6 gene were associated with
reduced susceptibility to artmether in parasite isolates from French Guiana [24], but similar
results have not been observed elsewhere.
Several lines of evidence support ART-induced oxidative stress as a plausible mechanism of
action [20]. The in vitro potency of ART against Plasmodium is enhanced synergistically by
the presence of increased oxygen tension or pro-oxidant drugs and inhibited by oxygen-radical
scavengers [7]. Erythrocyte membrane models show that heme-ART binding leads to greatly
enhanced heme-initiated oxidation and membrane damage, possibly through lipid peroxidation
[25,26]. ART exposure results in the production of reactive oxygen species (ROS) in both yeast
cells and mammalian tumor cells [27,28].
Confocal microscopy experiments with live P. falciparum demonstrated that fluorescent
acridine ART derivatives localize uniformly in the parasite cytoplasm in an iron-dependent,
covalent manner [8,23]. However, an ART-nitrobenzyldiazole conjugate, a fluorophore not
quenched by heme, localized to the DV as well as the cytoplasm [8]. In these earlier studies,
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the effect of the endoperoxide bridge on accumulation was not directly investigated however.
Here, we report on the chemical basis of localization and toxicity of the endoperoxides in P.
falciparum. Using epifluorescence microscopy, we examined the intracellular distribution of
novel fluorescent ART trioxane derivatives in living parasite-infected erythrocytes (Fig. 1,
3-6). We compared a synthetic trioxane with several ART-based dimers and show that the
endoperoxide pharmacophore underlies the specific accumulation of both structural types into
neutral lipid bodies of trophozoite- and schizont-stage parasites. A fluorescent ART probe, in
which the endoperoxide bridge was replaced by an ether linkage, accumulated non-specifically
in the parasite cytoplasm and showed only minimal activity against P. falciparum. We further
show that the endoperoxide function was required to mediate changes in lipid composition and
induce membrane peroxidation.

2. Materials and Methods
2.1 Parasite culture
P. falciparum strain Dd2 was cultured in human AB+ erythrocytes at 37 °C using RPMI 1640
(Mediatech, Herdon, VA) media supplemented with 0.5% Albumax I (Invitrogen, Carlsbad,
CA), 0.25% NaHCO3, and 0.01 mg/ml gentamicin (MP Biomedicals, Irvine, CA), under an
atmosphere of 90% nitrogen, 5% oxygen, and 5% carbon dioxide. When required, parasite
synchrony was maintained with 5% sorbitol treatment [29].
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2.2 Synthesis of fluorescent compounds
Reagents—All chemicals, including ART and dihydroartemisinin were purchased from
Sigma (St. Loius, MO) unless otherwise stated. Dansyl chloride and 7dimethylaminocoumarin-4-acetic acid were purchased from Molecular Probes (Eugene, OR).
Solvents were supplied by Fisher Scientific (Pittsburgh, PA) or EMD Chemicals Inc. (La Jolla,
CA) and were distilled to make anhydrous.
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Synthesis of Deoxydihydroartemisinin (dDHA; 2)—Dihydroartemisinin (0.5 g, 1.8
mmol) was dissolved in glacial acetic acid (20 ml) and stirred at room temperature under argon.
When all the dihydroartemisinin had dissolved, zinc dust (0.89 g, 13 mmol), which was washed
with 5% HCl (100 ml), ddH2O (100 ml), EtOH (100 ml), and diethyl ether (100 ml), dried in
vacuo, and stored under argon, was added. The mixture was then stirred for 5 h to completion.
The mixture was filtered through a pad of Celite and washed with CHCl3 (50 ml). The solution
was then portioned between CHCl3 (100 ml) and ddH2O (100 ml). The layers were separated
and the organic layer was washed with saturated sodium bicarbonate (3 × 100 ml) and brine,
dried over Na2SO4, filtered and evaporated to a white solid. Purification by column
chromatography (10% EtOAc/90% petroleum ether, then 100% EtOAc) gave the product
dDHA as a white solid (0.24 g, 0.90 mmol, 50%) in a 2:1 mixture of isomers; mp = 134-136
°C.
Synthesis of Trioxane-CH2CH2O-dansyl (12C; 3)—12C was synthesized according to
published methods [30].
Synthesis of Artemisinin-dimer-CH2O-dansyl (ADD; 4)—Bis-trioxane primary
alcohol was synthesized according to published protocols [31]. Dansyl chloride (134 mg, 0.495
mmol) was dissolved in dichloromethane (7 ml) with triethylamine (69 μl, 0.495 mmol) and
stirred for 10 min. Bis-trioxane primary alcohol (100 mg, 0.165 mmol) was added and stirred
at reflux for 18 h. The reaction was then allowed to cool and concentrated in vacuo. The crude
product was purified by flash silica gel column chromatography (20% EtOAc/hexanes) to yield
ADD as a bright yellow solid (101 mg, 0.120 mmol, 73%). mp = 110-112 °C; [α]D22.5 +40.62°
(c = 0.09, CHCl3). IR (CH2Cl2, film) 2938, 2875, 1713, 1575, 1454, 1376, 1356, 1176, 1105,
Biochem Pharmacol. Author manuscript; available in PMC 2010 February 1.
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1053, 1008, 943, 881, 842, 790, 735, 632, 575; 1H NMR (400 MHz, CDCl3) δ 8.61 (br s, 1H),
8.33-8.27 (m, 2H), 7.58-7.52 (m, 2H), 7.20 (br s, 1H), 5.10 (s, 1H), 5.09 (s, 1H), 4.27-4.06 (m,
4H), 2.91 (s, 6H), 2.58-2.50 (m, 1H), 2.31-2.10 (m, 4H), 2.00-1.82 (m, 4H), 1.72-1.55 (m,
10H), 1.54-1.04 (m, 14H), 0.98-0.84 (m, 8H), 0.75-0.65 (m, 6H); 13C NMR (100 MHz,
CDCl3) δ 131.63, 131.09, 130.55, 129.99, 129.86, 128.33, 123.31, 119.83, 115.29, 102.96,
102.40, 89.40, 88.90, 81.06, 80.88, 73.55, 73.01, 69.74, 52.28, 51.95, 45.48, 44.24, 43.88,
37.38, 37.33, 36.59, 34.46, 34.38, 33.82, 30.90, 30.41, 30.28, 29.59, 25.99, 25.90, 24.74, 24.67,
20.24, 20.06, 12.84, 12.30; HRMS (FAB-MS) m/z calculated for C46H65NO11S (M+H)+
840.4357, found 840.4352. To examine the possibility that the C-10 dansyl-linked fluorescent
tag could be released by intraparasitic hydrolysis, ADD was dissolved in DMSO:D2O at pH
7.4. After 0.5 h at 37 °C, the ADD dansyl sulfonate ester was approximately 20% hydrolyzed
back into its parent primary alcohol.
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Synthesis of Deoxy-dimer Primary Alcohol—Zinc powder (192 mg, 2.94 mmol) was
washed consecutively with 5% HCl (50 ml), ddH2O (50 ml), EtOH (50 ml), diethyl ether (50
ml) and dried in vacuo. Bis-trioxane primary alcohol (120 mg, 0.198 mmol) was dissolved in
glacial acetic acid (12 ml). The washed zinc was added to the acetic acid and stirred at room
temperature for 2 h. The mixture was then filtered through Celite using CHCl3. Filtrate was
concentrated in vacuo to remove CHCl3. The solid was then dissolved in dichloromethane (10
ml) and washed with saturated NaHCO3 (2 × 10 ml). The organic layer was dried with
MgSO4, filtered, and concentrated in vacuo. The crude product was purified by flash silica gel
column chromatography (40% EtOAc/hexanes) to yield deoxy-dimer primary alcohol as a
white solid (93.0 mg, 0.162 mmol, 82%). mp = 84-85 °C; [α]D23.2 − 110.76° (c = 0.080,
CHCl3). IR (CH2Cl2, film) 3524, 2950, 2875, 1456, 1384, 1266, 1208, 1178, 1141, 1099, 996,
925, 877, 735; 1H NMR (400 MHz, CDCl3) δ 5.27 (s, 1H), 5.26 (s, 1H), 4.28-4.17 (m, 2H),
3.77-3.57 (m, 2H), 2.46 (br s, 1H), 2.22-2.16 (m, 2H), 1.96-1.39 (m, 24H), 1.29-1.12 (m, 9H),
0.98-0.83 (m, 12H); 13C NMR (100 MHz, CDCl3) δ 107.14, 107.07, 97.23, 97.18, 82.45, 67.25,
65.09, 64.11, 45.36, 40.47, 35.72, 35.61, 34.57, 32.85, 32.63, 30.13, 30.00, 25.21, 23.73, 23.69,
22.19, 18.80, 12.16; HRMS (FAB-MS) m/z calculated for C34H54O7 (M+H)+ 575.3948, found
575.3943.
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Synthesis of Deoxy-artemisinin-dimer-CH2O-dansyl (dADD; 5)—Dansyl chloride
(42 mg, 0.157 mmol) was dissolved in dichloromethane (2 ml) with triethylamine (22 μL, 0.157
mmol) and stirred for 10 min. Deoxy-dimer primary alcohol (30 mg, 0.052 mmol) was added
and stirred at reflux for 18 h. The reaction was then allowed to cool and was concentrated in
vacuo. The crude product was purified by flash silica gel column chromatography (20% EtOAc/
hexanes) to yield dADD as a bright yellow solid (24.5 mg, 0.0303 mmol, 58%). mp = 100-110
°C; [α]D21.1 −86.45° (c = 0.485, CHCl3). IR (CH2Cl2, film) 2953, 2872, 1574, 1459, 1384,
1358, 1266, 1206, 1176, 1142, 1100, 1010, 926, 877, 791, 736, 630; 1H NMR (400 MHz,
CDCl3) δ 8.56-8.54 (d, J = 8.8 Hz, 1H), 8.31-8.29 (d, J = 8.8 Hz, 1H), 8.27-8.25 (m, 1H),
7.57-7.49 (m, 2H), 7.16-7.14 (d, J = 7.6 Hz, 1H), 5.05 (s, 1H), 4.89 (s, 1H), 4.31-4.08 (m, 2H),
4.05-3.96 (m, 2H), 2.87 (s, 6H), 2.10-1.94 (m, 3H), 1.85-1.75 (m, 4H), 1.69-1.00 (m, 22H),
0.97-0.83 (m, 12H), 0.74-0.72 (d, J = 7.6 Hz, 3H), 0.53-0.51 (d, J = 7.6 Hz, 3H); 13C NMR
(100 MHz, CDCl3) δ 131.84, 130.98, 130.49, 130.13, 128.34, 123.00, 119.99, 115.21, 106.75,
106.65, 96.92, 96.87, 82.19, 82.08, 74.05, 65.76, 64.24, 45.46, 45.32, 45.29, 40.55, 40.35,
35.48, 34.55, 32.61, 31.91, 30.19, 29.76, 29.52, 24.98, 24.92, 23.71, 23.60, 22.16, 18.81, 12.30,
11.87; HRMS (FAB-MS) m/z calculated for C46H65NO9S (M+H)+ 808.4458, found 808.4513.
Synthesis of Artemisinin-dimer-CH2O-coumaryl (6)—Bis-trioxane primary alcohol
(98 mg, 0.16 mmol), 7-dimethylaminocoumarin-4-acetic acid (20 mg, 0.081 mmol) and 4dimethylaminopyridine (10 mg, 0.08 mmol) were added to dichloromethane (7 ml) under
argon. N, N′-dicyclohexylcarbodiimde (17 mg, 0.08 mmol) was added and the reaction was
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stirred at room temperature for 18 h. The orange solution was concentrated in vacuo. The crude
product was purified by flash silica gel column chromatography (20 to 30% EtOAc/hexanes)
to yield artemisinin-dimer-CH2O-coumaryl as an amorphous pale yellow solid (28 mg, 0.033
mmol, 41%); [α]D22.3 +52° (c = 0.18, CHCl3). IR (thin film) 3057, 2951, 2876, 1719, 1619,
1532, 1453, 1403, 1375, 1268, 1145, 1105, 1053, 1008, 735, 702 cm-1; 1H NMR (400 MHz,
CDCl3) δ 7.43-7.41 (d, J = 8.8 Hz, 1H), 6.64-6.61 (m, 1H), 6.51-6.50 (d, J = 2.0 Hz, 1H), 6.05
(s, 1H), 5.23 (s, 1H), 5.22 (s, 1H), 4.33-4.16 (m, 4H), 3.70 (s, 2H), 3.04 (s, 6H), 2.61-2.59 (m,
1H), 2.39-2.38 (m, 1H), 2.32-2.24 (m, 2H), 2.11-1.87 (m, 6H), 1.73-1.55 (m, 9H), 1.42-1.13
(m, 17H including singlets at 1.37 and 1.36), 0.95-0.85 (m, 9H), 0.78-0.76 (d, J = 7.2 Hz, 3H),
0.71-0.69 (d, J = 7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 168.9, 161.6, 155.9, 152.7,
148.9, 125.6, 110.8, 109.2, 108.9, 103.2, 102.8, 98.4, 89.6, 88.9, 81.2, 81.1, 73.6, 70.5, 67.1,
52.3, 52.1, 44.4, 44.1, 40.2, 38.6, 37.5, 36.7, 36.6, 34.5, 34.4, 34.0, 30.1, 30.6, 30.4, 30.2, 26.1,
26.0, 24.8, 20.3, 20.1, 13.0, 12.5; HRMS (FAB) m/z calculated for C47H65NO12 (M+H)+
836.4585, found 836.4578.
2.3 Drug Susceptibility Testing
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Prior to testing, the structures of all new compounds were characterized by proton and 13C
NMR spectroscopy and by high-resolution mass spectrometry. All drugs were prepared as 10
mM stock solutions in DMSO or MeOH and stored at -30 °C. The in vitro susceptibility of P.
falciparum to the various drugs was measured in a 72 h microplate growth assay using SYBR
Green I (Molecular Probes) detection as described [32,33]. Mean half-maximal inhibitory
concentrations (IC50 values) were derived by plotting percent growth inhibition against log
drug concentration and fitting the response data to a variable slope sigmoidal curve-fit function
using Prism 4.0c (GraphPad, San Diego CA). IC50 values represent means ± standard error
from at least 3 independent assays.
2.4 Fluorescence microscopy and image analysis
For live cell imaging, all culture or parasite samples were washed twice with PBS and mounted
under coverslips with Slowfade Antifade Reagent (Invitrogen) in PBS. Isolated DVs were
mounted in a similar fashion. Samples were viewed with 100X oil-immersion on an AX70
Olympus PROVIS U-CMAD3 epifluorescence microscope equipped with a 100W mercury
bulb using U-MWU, U-MWB or U-MWG filter sets. Micrographic images were recorded using
the Olympus DP70 camera system, and compiled and analyzed with Olympus DP Manager
software and Photoshop CS v8.0 (Adobe Systems Incorporated, San Jose, CA).
2.5 Localization of 12C, ADD and dADD in P. falciparum
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Mixed-stage P. falciparum cultures were exposed to 1 μM 12C or 1 μM ART for 10 min, or
500 nM ADD, 500 nM dADD, or 500 nM ADD plus 500 nM dADD for 30 min. Parasites were
viewed directly or were first released from erythrocytes using 0.2% saponin. DVs from drug
treated parasites were isolated according to published protocols [34,35].
2.6 Sub-cellular parasite labeling
Nile Red (ACROS Organics, Morris Plains, NJ) stock solution was prepared in MeOH at 1
mg/ml and stored at 4 °C. MitoTracker Red 580, Lysosensor Green 189, ERTracker Green,
DAPI nucleic acid stain and BODIPY 505/515 stock solutions were diluted in RPMI or PBS
immediately prior to use and applied to live cultures according to the manufacturer's (Molecular
Probes) suggested concentrations (see below). Prior to each experiment, fresh dilutions were
made in RPMI or PBS. Trophozoite-stage parasite cultures (1% parasitemia) were incubated
under one of the following conditions: 50 nM Lysosensor Green 189 for 1 min; 1 μM DAPI
for 10 min; 1 μM ERTracker Green for 30 min, 500 nM MitoTracker Red 580 for 1 h, 500 nM
BODIPY 505/515 for 30 min or 30 nM Nile Red for 10 min. Following incubation, cultures

Biochem Pharmacol. Author manuscript; available in PMC 2010 February 1.

Hartwig et al.

Page 6

NIH-PA Author Manuscript

were exposed to 500 nM 12C for 10 min. With the exception of Lysosensor Green 189 and
DAPI, cultures were first released from erythrocytes with 0.2% saponin prior to microscopic
visualization to enhance fluorescence signal detection. For stage-specific accumulation of 12C
and Nile Red, sorbitol-synchronized parasites, corresponding to six stages of intraerythrocytic
growth, were subjected to the following treatments for 10 min prior to mounting for
microscopy: drug-vehicle (0.01% MeOH), 30 nM Nile Red, 1.0 μM 12C or 12C plus Nile Red.
Giemsa-stained thin smears were photographed under light microscopy at each time-point to
verify parasite stage. All stages, except for rings, were treated with 0.2% saponin for maximum
fluorescence detection.
2.7 12C Competition experiments
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Synchronized trophozoite-stage cultures were exposed to either 500 nM ART, 500 nM dDHA
or drug vehicle (0.01% MeOH) in pre-warmed complete media and incubated at 37 °C. After
10 min, the media was removed and replaced with fresh, pre-warmed complete media
containing 500 nM 12C. Following 10 min incubation, parasites were washed, released with
0.2% saponin and processed for microscopy. The percentage of parasites showing detectable
12C neutral lipid body (NLB) fluorescence was determined from 20 fields of view for each
pre-treatment group (approximately 100 parasites per group). Mean volume of positive 12C
signal from NLB for each pre-treatment group (consisting of 20-110 signals) was calculated
from the intensity and area of signal in each frame using QuantityOne (Bio-Rad, Hercules,
CA) software. Statistical analysis of pre-treatment effects on the percentage of 12C-positive
parasites was evaluated with ANOVA and Tukey's post-hoc test (p < 0.05) for multiple
comparisons. Pre-treatment effects on the mean volume of 12C signal for each pre-treatment
group were evaluated using ANOVA (p < 0.05) and the Satterwhite approximation for degrees
of freedom for unequal sub-sample comparisons [36]. Analyses were conducted with SPSS
v16.0. Reciprocal experiments in terms of drug exposure order were conducted in the same
fashion. Parasite cultures were first exposed to 500 nM 12C for 10 min, followed by 10 min
ART post-treatment at 500 nM and 2 μM. All experiments were run in triplicate (N = 3).
2.8 Post-wash retention of ADD and dADD
Mixed-stage parasite cultures were treated with either 500 nM ADD or 500 nM dADD.
Following 30 min drug exposure, cultures were washed in 37 °C complete media to remove
drug, resuspended in drug-free complete media and incubated at 37 °C. At 10, 30, and 60 min
post-wash, aliquots were removed from culture and parasites were released with 0.2% saponin
and immediately processed for microscopy.
2.9 Thapsigargin and desferrioxamine inhibition experiments
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Thapsigargin (Alexis, San Diego, CA), and desferrioxamine (Calbiochem, San Diego, CA)
were resuspended in DMSO and ddH2O, respectively, to a final concentration of 100 mM.
Cultures of trophozoite-stage parasites were treated with 500 nM thapsigargin for 10 min or
100 μM desferrioxamine for 1 h, followed by either 500 nM 12C or 30 nM Nile Red staining
for 10 min. Parasites were released from erythrocytes with 0.2% saponin prior to microscopic
imaging.
2.10 Lipid peroxidation studies using BODIPY 581/591 C11
The fluorescent BODIPY 581/591 C11 peroxidation-sensitive probe (Molecular Probes) was
reconstituted to 40 μM in DMSO and stored under N2. At ring, trophozoite and segmenterstages, parasite cultures were exposed to 250 nM ART, 250 nM dDHA, 250 nM mefloquine
(kindly provided by Dr. Thomas Wellems, National Institutes of Health, Bethesda, MD) or
vehicle control (0.01% MeOH). After 3 h of drug exposure, cultures were labeled with 40 nM
BODIPY 581/591 C11 and returned to 37 °C for an additional 30 min. Ring and segmenter-
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stage parasites occurred simultaneously in culture and were not saponin-released due to the
difficulty pelleting freed ring-stage parasites, whereas trophozoite-stage parasites were
released from erythrocytes using 0.2% saponin prior to visualization.
2.11 Thin-layer chromatographic analysis of lipids
Cultures of synchronous trophozoite-infected erythrocytes were treated with either 1 μM ART,
1 μM dDHA, 1 μM mefloquine or vehicle control (0.01 % MeOH) for 5 h. Cultures were
washed in PBS and erythrocytes were lysed with 0.2% saponin treatment. Cell pellets were
extracted for total lipids with CHCl3: MeOH: ddH2O (8:4:3) according to established methods
[37,38]. Control lipid extracts from uninfected erythrocytes, or uninfected erythrocytes treated
with 1 μM ART, were prepared in a parallel fashion. Samples were dried under N2 and
resuspended in 50 ml of CHCl3. Ten μl of each extract was applied to Silica Gel 60 thin layer
chromatography (TLC) plates (Whatman, Florham Park NJ), corresponding to ∼2.5 × 108
parasites, or ∼5 × 109 uninfected control erythrocytes. Non-polar lipid standards (Matreya,
Pleasant Gap, PA) prepared in CHCl3, at a final concentration of 25 mg/ml of each lipid species
served as a reference for lipid extracts. Plates were visualized with 5% phosphomolybdic acid
[39] (ACROS Organics) for overall lipid detection, or Liebermann-Burchard reagent [40] for
specific sterol content, followed by heating at 110 °C for 5-10 min. Plates were photographed
under transient illumination. Image background was adjusted using QuantityOne software
(Bio-Rad).
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3. Results
3.1 The fluorescent trioxane, 12C, accumulates in neutral lipid bodies

NIH-PA Author Manuscript

We used epifluorescence microscopy to study the intracellular distribution of a fluorescenttagged endoperoxide in living, P. falciparum-infected erythrocytes. The first endoperoxide we
explored was compound 12C, a synthetic trioxane dansylate (Fig. 1, 2) whose synthesis and
activity was described in an earlier study [30]. Growth-inhibition assays confirmed that 12C
(IC50 = 5.5 nM) was equipotent to ART (IC50 = 6.9 nM) against the Dd2 strain of P.
falciparum. ART and other endoperoxide drugs rapidly accumulate into P. falciparum-infected
red blood cells [8,41] and are exceptionally fast-acting antimalarials [42]. Therapeutic plasma
concentration of ART derivatives can achieve micromolar levels shortly after administration
[43]. Therefore, to clearly detect fluorescence, we treated trophozoite-stage parasite cultures
with 1 μM 12C for 10 min prior to microscopy. Fluorescence was observed as small, intensely
bright spheres found in the parasite cytoplasm in proximity to the DV, which was distinguished
by the presence of the dark hemozoin crystals (Fig. 2A; white arrowheads). Occasionally, faint,
diffusive cytoplasmic fluorescence was noted in addition to the punctate labeling (not shown).
No labeling was detected in uninfected red blood cells, demonstrating the specificity of drug
accumulation by P. falciparum. No fluorescence was detected from control cultures treated
with ART, showing that the 12C signal was not due to an inherent property of the endoperoxides
to generate fluorescent metabolites. An earlier study showed labeling by a fluorescent ARTacridine conjugate in small membraneous structures of the erythrocyte cytoplasm, possibly
corresponding to the parasite tubovesicular network [23]. Therefore, we released 12C-treated
parasites from erythrocytes by saponin treatment prior to imaging (Fig. 2B). Parasite labeling
was identical to that of infected erythrocytes, indicating that the fluorescence was contained
within the parasite as opposed to the host erythrocyte cytoplasm. Finally, fluorescent labeling
remained physically associated with the DV following their isolation by hypotonic lysis of the
parasite membrane (Fig. 2C). Next, we examined the specificity of 12C labeling by comparing
its intracellular distribution with that of fluorescent organellar and lipid probes. Merged images
of trophozoite-infected erythrocytes and saponin-released trophozoites, counter-stained with
probes specific for the DV, mitochondria, endoplasmic reticulum or nucleus, all show the
distinct and separate localization of 12C (Fig. 3A). Depending on the orientation of the parasite,
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the images often suggested that the 12C-labeled spots resided within the DV compartment.
However, further studies routinely show they were located peripherally as opposed to
internally. Parasites co-stained with 12C and the lipid probes BODIPY 505/515 or Nile Red
showed overlapping, intense punctate fluorescence at the DV periphery, suggesting that the
12C-staining spots were lipid-rich.

NIH-PA Author Manuscript

From recent detailed imaging studies of the Plasmodium lipid environment, Nile Red has been
shown to stain membrane structures of infected erythrocytes [37,44]. The most intensely
stained regions were small cytoplasmic lipid droplets located adjacent to the DV exterior. These
structures were identified as NLB, composed mostly of triacylglycerols (TAG). NLB are easily
differentiated from parasite membranes as the spectral emission of Nile Red is based on the
hydrophobicity of the lipid environment in which it is found [45]. Nile Red emits an intense
yellow-green fluorescence when incorporated in neutral lipids, while polar lipids and
phospholipids promote orange-red fluorescence (Fig. 3A). The clear overlap of 12C and Nile
Red, shown in Fig. 3A, indicates that 12C fluorescence is specifically located in the NLB. We
therefore studied the labeling patterns of 12C and Nile Red throughout the asexual stages of
intraerythrocytic parasite growth. Parasite cultures exposed to 30 nM Nile Red for 10 min
showed increasing numbers of NLB from the early trophozoite to schizont stages (Fig. 3B).
When we applied 1 μM 12C to the parasites for 10 min, we observed a stage-specific labeling
pattern that mimicked that of the Nile Red-stained NLB. Co-staining 12C-treated parasites
with Nile Red resulted in overlap of the intense signal associated with the NLB, seen as a shift
in the emission spectra compared to 12C or Nile Red alone. Labeling with either compound in
ring-stage parasites resulted in faint fluorescence. In segmenter stages, 12C fluorescence was
detected surrounding each merozoite in addition to the brighter signal of the NLB. Overlap of
segmenter staining by 12C and Nile Red confirmed the affinity for the merozoites by both
compounds.
3.2 ART specifically inhibits localization of 12C

NIH-PA Author Manuscript

Structurally diverse antimalarial endoperoxides vary in their cellular effects and affinity for
different targets [13,19,46]. Therefore, we performed competition studies to determine if the
NLB localization of 12C was also representative of ART. Parasite cultures were pre-treated
for 10 min with either 500 nM ART or the inactive dioxolane, dDHA (Fig. 1; 2), then exposed
to 500 nM 12C for an additional 10 min prior to imaging. Compared to the MeOH controls,
no significant reduction of 12C fluorescence in NLB was detectable with dDHA pre-treatment
(Fig. 4A). In contrast, when compared to the MeOH controls, ART pre-treatment resulted in
a 77.1 ± 2.6% decrease in the number of parasites showing any detectable NLB fluorescence
from 12C (p < 0.01) and a 74.6 ± 3.4% percent decrease compared to dDHA pre-treated controls
(p < 0.05). Among parasites that contained fluorescing NLB in the ART pre-treatment group,
the mean 12C signal volume was reduced by 72.4 ± 5.2% compared to control cells (p < 0.01;
Fig 4B). No significant difference was detected in mean NLB 12C signal volume between
control cells pre-treated with MeOH or dDHA. The data suggest that ART and 12C share a
similar ability to accumulate in NLB in an endoperoxide dependent process. The finding that
the inactive dDHA did not decrease the 12C signal suggests that ART and 12C may compete
for binding or endoperoxide activation, as opposed to competing for uptake into the parasite.
We next reversed the drug exposure protocol by pre-treating cultures with 500 nM 12C for 10
min and followed with equimolar or four-fold excess ART. In either case, no displacement of
fluorescent labeling or decrease in signal intensity within NLB was observed (Fig. 4C). Taken
together, these results indicate that labeling patterns were a result of activation of the 12C
endoperoxide moiety followed by alkylation of a target found within, or subsequently
sequestered within, the NLB.
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3.3 Accumulation pattern of ART-derived dimers is endoperoxide-dependant

NIH-PA Author Manuscript
NIH-PA Author Manuscript

Recently, a series of novel ART-derived trioxane dimers were shown to be highly potent and
curative against murine malaria [47]. Based on this synthesis approach, we developed a
matched pair of ART dimers conjugated to the same dansyl ester fluorophore used to construct
12C. These two dimers differed only in the presence of an endoperoxide or ether linkage within
the ART framework, thus allowing the direct investigation of drug activation on cellular
localization. Against the Dd2 strain of P. falciparum, in vitro drug assays showed that the
trioxane ADD (Fig. 1; 4) was equipotent to ART and 700-fold more potent than the dioxolane
derivative dADD, (Fig. 1; 5). Following treatment of cultures with 500 nM ADD for 30 min,
bright fluorescence was detected in NLB in a pattern similar to 12C (Fig. 5A). In contrast,
treatment with dADD resulted in uniform, cytoplasmic fluorescence with no evidence of
specific organellar localization, including the NLB. When 500 nM ADD and dADD were
administered to cultures simultaneously, the separate localization of each drug was clearly
evident. Similar to what we observed for 12C in segmenter stages, ADD showed an affinity
for labeling both the NLB and merozoites (Fig. 5B). As segmenters matured to the near release
stage, NLB labeling became less distinct while the individual merozoite signal became more
intense. The inactive dADD showed only weak, diffusive labeling of the segmenter stages,
again demonstrating the necessity of the endoperoxide for specific drug localization. The
cytoplasmic labeling and lack of anti-plasmodial activity by dADD illustrated important
features of the dansyl tag: fluorescence was not attenuated when the drug was found in an
aqueous compartment, nor did it impart potency or cause the probes to partition in lipid
compartments. The starkly contrasting localization of the probes also argues that the visible
fluorescence was not due to loss of the dansyl probe through hydrolysis of the C-10 linkage.
Since intracellular labeling patterns by the ART dimers were endoperoxide dependent, we
tested the hypothesis that ADD formed covalent adducts with target molecules, while
predicting that dADD was unlikely to bind covalently. We treated parasites with 500 nM ADD
or dADD for 30 min, removed drug from the cultures with fresh media changes and imaged at
various time points post-wash (Fig. 5C). At 10 min post-wash, ADD-treated parasites retained
bright fluorescence in the NLB, but the signal gradually diminished by 60 min post-wash. In
contrast, washing of dADD-treated parasites resulted in a rapid dissipation of the cytoplasmic
fluorescence, which was barely detectable after 30 min. These findings suggested that ADD
binds tightly to its target(s) within the NLB, but turnover of this binding site occurred, as signal
was gradually lost after 60 min. In keeping with its low potency, the rapid disappearance of
dADD fluorescence suggests that the drug does not posses strong binding affinity for specific
molecular targets.
3.4 Effect of ART inhibitors thapsigargin and desferrioxamine on 12C labeling
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In P. falciparum, ART was shown to inhibit cytoplasmic labeling by a fluorescent thapsigargin
analog, presumably by competitively binding the SERCA analog, PfATP6 [23]. Therefore, we
used thapsigargin pre-treatment to study the possible involvement of PfATP6 in the
intracellular distribution pattern of 12C. We found that pre-treatment with 500 nM thapsigargin
for 10 min had no effect on equimolar 12C localization in the NLB (Fig. 5D). Staining of
thapsigargin-treated parasites with Nile Red demonstrated that NLB formation was unaffected
by thapsigargin pre-treatment. These results rule out PfATP6 involvement in the localization
of 12C to NLB.
Desferrioxamine, a chelator of free ferric iron, antagonizes the potency of ART and abolishes
the irreversible binding of fluorescent ART derivatives in P. falciparum-infected erythrocytes
[8,48]. We therefore examined the effect of desferrioxamine on NLB labeling by 12C in
trophozoites. In addition to the bright labeling of NLB, pretreatment with 100 μM
desferrioxamine for 1 h followed by 500 nM 12C resulted in substantial cytoplasmic
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fluorescence, (Fig. 5D). Staining with Nile Red demonstrated that desferrioxamine pretreatment had no observable effect on the presence of NLB. The diffusive cytosolic 12C
staining resulting from desferrioxamine pretreatment, resembled that of the inactive dimer,
dADD (Fig. 5A), suggesting that some of the 12C taken up by parasites was not subjected to
endoperoxide activation. The continued labeling of NLB suggested that despite chelating with
desferrioxamine additional sources of iron remained available to activate a portion of the 12C.
These findings nonetheless demonstrate that iron-catalyzed activation of endoperoxides is
likely an important step in the accumulation of 12C within NLB.
3.5 Formation of reactive oxygen species in parasite membranes is endoperoxide-dependent
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ART has been shown to cause oxidative damage to red blood cell and yeast membranes through
formation of iron-catalyzed free radicals and formation of downstream ROS [25,26,28]. Given
the selective accumulation of 12C and ADD in neutral lipids, we used BODIPY 581/591
C11 to test for the presence of ROS in the parasite membrane system following exposure to
ART. A fluorescent fatty acid, BODIPY 581/591 C11 is efficiently incorporated into cellular
membranes and is oxidized by various radicals, causing the normal red fluorescence to shift
to green [49]. Parasite cultures were treated with various drugs at 250 nM for 3 h and coincubated with BODIPY 581/591 C11 for 30 min prior to imaging under epifluorescence
microscopy (Fig. 6A). Control cells showed strong incorporation of the lipid probe at all stages,
and retention of the red fluorescence indicated that no auto-oxidation occurred during
processing. In contrast, BODIPY 581/591 C11 rapidly oxidized in ring, trophozoite and
segmenter-stage parasites treated with ART, consistent with reports of ART potency against
all asexual blood stages of the parasite [17]. Incorporation of the probe into membrane appeared
non-specific, and all labeled areas showed extensive oxidation following ART treatment. The
yellow/green probe color was less intense in the ring-stage parasites compared to later stages,
consistent with the diminished quantity of 12C labeling of rings shown in Fig. 3B. Cultures
treated with inactive dDHA showed red fluorescence identical to controls, indicating the probe
had not been oxidized (Fig. 6A). We also treated BODIPY 581/591 C11 labeled cells with 250
nM mefloquine, a potent quinoline alcohol that binds heme with high affinity [50]. Treatment
with mefloquine resulted in no observable shift in the emission spectra of the probe. These
results confirmed that the endoperoxide group of ART was required to induce oxidative
processes in the membranes of P. falciparum. We observed that the oxidation of BODIPY
581/591 C11 was minimal if cells were labeled promptly after ART exposure (data not shown).
Rather, the probe emission shift began to peak at least 3 h post-ART exposure, suggesting that
oxidation may be due to downstream ROS species formed in chain reactions within the
membrane.
3.6 ART exposure alters composition of lipid species in parasitized erythrocytes
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We used TLC analysis to determine if ART exposure affected the lipid content of P.
falciparum. Lipid extracts, from saponin-lysed, infected and uninfected erythrocytes exposed
to 5 h drug-treatment, were separated on silica plates in a two-stage solvent system that resolves
both phospholipids and neutral lipids (Fig. 6B, i) [37]. Exposure to 1 μM ART had no
observable effect on the lipid composition of uninfected erythrocytes (Fig. 6B, i, lanes 1-2).
Compared to uninfected erythrocytes, infected cells were enriched in phospholipids and TAG
(lanes 3-6) as reported elsewhere [37, 44]. Drug-vehicle, dDHA and mefloquine had no effect
on any of the lipid species resolved from trophozoite-infected cells (lanes 3-5). However,
treatment of infected erythrocytes with 1 μM ART resulted in the appearance of two additional
bands compared to controls (lane 6). The smaller band co-migrated with the fatty acid (FA)
standard, while a larger band co-migrated with the cholesterol oleate (a cholesteryl ester; CE)
standard. Because P. falciparum is not known to synthesize CE, we sprayed plates with
Liebermann-Burchard reagent to verify the presence of sterols (Fig. 6B, ii) [40]. The additional
band from the ART-treated parasites both co-migrated and stained the same brown-violet color
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as the CE standard, but distinct from the violet-staining cholesterol (CL), strongly suggesting
the presence of a CE. The presence of the FA and CE bands was both parasite and endoperoxide
dependent. The identification of the larger band as a possible CE not normally found in P.
falciparum suggests these lipids resulted from free radical processes initiated by parasiteactivated ART.

4. Discussion
We investigated the cellular targets of antimalarial endoperoxides using novel fluorescenttagged ART trioxane derivatives in conjunction with microscopic imaging of living P.
falciparum parasites. Supporting the hypothesis of ART bioactivation, we show that the
endoperoxide pharmacophore underlies the accumulation of drug metabolites in parasite
neutral lipid compartments and their ability to initiate oxidative membrane damage. Our probes
were based on a synthetic tricyclic trioxane (12C) or semi-synthetic ART-derived dimers (ADD
and dADD) [30,31], both conjugated with a dansyl fluorophore. Both 12C and ADD were of
similar potency (IC50 values from 1.2-16.3 nM) to ART (6.9 nM) against the Dd2 strain of P.
falciparum. The inactive dioxolane dimer, dADD (IC50 = 2730 nM) was structurally identical
to ADD, except that dADD contained ether linkages instead of endoperoxide bridges and was
therefore not susceptible to iron-catalyzed activation.
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P. falciparum-infected erythrocytes rapidly accumulated both pharmacologically active and
inactive fluorescent probes. Beginning with early trophozoite stages, 12C and ADD labeling
closely overlapped the characteristic bright yellow-orange staining of NLB by Nile Red [37,
44,51]. NLB are small lipid droplets composed primarily of TAG, diacylglycerol or sterol
esters and appear ubiquitously in eukaryotic cells [52]. In Plasmodium, they are likely
reassembled from phospholipids derived from membrane-bound, hemoglobin-filled vesicles
that are ingested into the DV. NLB may provide energy and precursors for membrane
biogenesis in the maturing parasite. [53]. In the DV, neutral lipid nanospheres are believed to
concentrate the lipophilic free heme, while promoting hemozoin crystallization at the lipidcytosol interface [38]. This places neutral lipids in the same environment where heme-mediated
ART activation is predicted to take place.
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The immediate, striking disparity in NLB localization of 12C or ADD versus dADD in the
parasite cytoplasm provides strong evidence that endoperoxide activation and formation of
alkylating metabolites were necessary precursors to neutral lipid labeling. The inability of ART
to displace NLB labeling and the slow washout of ADD compared to dADD supports the
formation of covalently bound probe adducts. The dADD probe, lacking the endoperoxide
group, did not form tightly bound metabolites, as evidenced by the rapid washout of
fluorescence from the cell. One possible target of alkylation is TAG, although lipid-ART
adducts have yet to be documented. We thus favor heme as a more plausible target, as discussed
below.
Although 12C fluorescence was faint in ring-stage parasites, our results demonstrated
endoperoxide-induced lipid peroxidation in all parasite stages. This argues that rings contain
sufficient ferrous iron available for drug activation, consistent with recent studies showing that
rings more actively ingest hemoglobin than previously believed [54,55]. As parasites mature,
TAG-rich NLB accumulate around the DV periphery [44]. Prior to parasite release, NLB begin
to disperse and TAG is found surrounding the enclosed merozoites, resulting in a “bunch of
grapes” staining pattern with Nile Red [44]. The close overlap of Nile Red and 12C or ADD
in trophozoite and schizont NLB, as well as dispersed around growing merozoites, suggests
that the drug metabolites or adducts have a strong affinity for the highly lipophilic TAG-rich
compartments. Our results indicate that all asexual parasite stages should be susceptible to
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endoperoxides. However, literature reports of stage susceptibility to ART are variable and
contradictory [17], thus more studies are required to resolve these discrepancies.
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The cellular distribution of 12C and ADD sharply contrasts with earlier reports of cytoplasmic
and DV localization of fluorescent acridine- or nitrobenzyldiazole-conjugated endoperoxides
[8,23]. Physicochemical differences in the endoperoxide framework and the 2,6-dansyl
fluorophore may account for these observations. The substantially more polar acridine and
nitrobenzyldiazole tags (G. Posner, unpublished data) could bias probe localization away from
hydrophobic compartments. The inhibition of 12C NLB fluorescence by ART showed that the
specific localization of the dansyl-tagged probes was representative of other trioxane
derivatives, but does not rule out other ART targets. We also tested a coumaryl-conjugated
ART dimer (6), and found similar labeling of the NLB (data not shown). Interestingly, we did
not observe DV localization of our probes, suggesting that 12C and ADD fluorescence may
have been quenched by hemozoin and/or acidic pH, similar to the acridine trioxane probes
[8,19]. Alternatively, the immediate activation of 12C and ADD may have precluded DV
visualization.
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Chelating iron attenuates the cytotoxic effects of ART in Plasmodium, Saccharomyces and
cancer cells [8,28,48,56]. Here, desferrioxamine treatment did not inhibit uptake of 12C, but
a portion of the fluorescence remained in the parasite cytoplasm, similar to inactive dADD
labeling. Desferrioxamine may have removed free iron available for endoperoxide activation
and the resulting cytoplasmic fluorescence represented intact 12C. Since desferrioxamine
selectively binds free ferric iron [8], ferrous heme in the DV would remain available for
activation, and may correspond to the 12C observed in the NLB. The effects of chelation are
not easily explained because endoperoxides are relatively inert in the presence of ferric iron
[57], leading to the proposal that desferrioxamine might alter the intracellular ferric and ferrous
iron equilibrium [8].
The sesquiterpene lactone, thapsigargin, is a specific inhibitor of mammalian SERCA [58] and
has been shown to compete with ART for binding of the P. falciparum ortholog, PfATP6, when
expressed in Xenopus oocytes. In P. falciparum, thapsigargin blocked the cytoplasmic labeling
of an ART-acridine probe [58]. These observations led to the proposal that PfATP6 is the
primary target of ART alkylation and inhibition [23]. In direct contrast, thapsigargin showed
no ability to reduce the accumulation of 12C into NLB, indicating that interactions with
PfATP6 are unlikely to account for the labeling patterns we observed. In agreement with our
observations, recent isobole studies have failed to reproduce the proposed antagonistic
relationship between ART and thapsigargin [19].

NIH-PA Author Manuscript

Endoperoxide-induced oxidative stress has been proposed as a mechanism of action of ART
[7,20,28]. Earlier studies showed that ART greatly enhances heme-catalyzed lipid peroxidation
and oxidative protein damage in erythrocyte membrane preparations [25,26]. Our results with
the oxidation-sensitive probe, BODIPY 581/591 C11, demonstrated the formation of ARTinduced peroxyl radicals in parasite membranes during intraerythrocytic, asexual stages. The
generation of ROS by ART was endoperoxide-specific, as experiments with dDHA produced
no observable shift in the emission spectra of the probe. We found that BODIPY 581/591
C11 peroxidation was evident after 3 h exposure to ART, which also corresponded to the longer
incubation time required to detect CE and free FA. This suggests that accumulation of
endoperoxide metabolites in neutral lipids may be necessary to initiate peroxyl radical
formation among unsaturated lipids, whereas the detrimental effects of chain-propagating
reactions on parasite membranes are only evident following longer exposure times (> 3 h).
Alternatively, there may be a time lag as the antioxidant defenses of the parasite are exhausted.
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We found that ART caused an increase in the amount of free FA in the parasite. Normally,
large quantities of free FA are released in conjunction with TAG degradation in late
schizogony, possibly in association with erythrocyte rupture [44]. The localization of 12C and
ADD metabolites in TAG-rich compartments may induce premature breakdown of TAG into
free FA. Unsaturated FA are readily oxidized in the cell, and exposure to oxidized
polyunsaturated FA can markedly inhibit Plasmodium growth in vivo and in vitro [59]. Further
studies are needed to elucidate the structure(s) of the ART-induced FA to determine their
possible role in drug potency.

NIH-PA Author Manuscript

A surprising result was the appearance of an ART-induced CE in parasite lipid extracts. CL
esterification activity has not been detected in P. falciparum, although the genome contains
lecithin-cholesterol acyltransferase (LCAT) and acyl CoA:diacylglycerol transferase (DGAT)
genes, both with peak transcript expression levels in schizont stages [51,60,61]. CL is a neutral
lipid that is highly prone to free radical oxidation to form various oxysterol derivatives,
particularly in the presence of polyunsaturated FA peroxides [62,63]. Oxysterols are considered
better substrates for enzymatic esterification than CL itself [64], thus an oxysterol could
become a substrate for esterification activity by P. falciparum LCAT or DGAT. P.
falciparum incorporates host CL into it own membranes, where it is essential for the
maintenance of intracellular infection [44,61,65]. As CL is relatively scarce in parasite
membrane, esterification of this vital cellular component may be deleterious to parasite
survival. Structural verification of the putative CE will facilitate an understanding of the
biosynthetic pathway induced by ART.

NIH-PA Author Manuscript

In summary, the endoperoxide probes, 12C and ADD, despite having markedly different
chemical structures, specifically labeled neutral lipid compartments. Moreover, because ART
inhibited NLB labeling, our study agrees with previous results that indicate a common pathway
of activation and alkylation for structurally diverse endoperoxides in P. falciparum [8]. We
propose a model where ART trioxane derivatives rapidly accumulate in the DV and are
activated by neutral lipid-associated heme [38]. The reactive metabolites alkylate heme,
forming highly lipophilic adducts that remain trapped in the neutral lipids that are sequestered
in NLB on the DV exterior. Heme adducts of various endoperoxides are well described from
in vitro and in vivo studies [10-15] and are unlikely to be incorporated into hemozoin [15]. In
the NLB, heme adducts may initiate lipid peroxidation and generation of ROS due to the
abundance of unsaturated FA [20]. Heme induces substantial oxidative stress on the lipids of
P. falciparum. Large amounts of hydroxy fatty acids are generated in the parasite by hemecatalyzed peroxidation of phospholipids [66]. ART alkylation further enhances the oxidative
capacity of heme to damage lipid membranes [26]. These observations may explain DV
membrane damage as one of the earliest effects of ART in P. falciparum [19]. The quantitative
contribution of oxidative stress to the potency of the endoperoxides remains to be established.
However, the generation of ROS by ART derivatives in a variety of eukaryotic cell types
[27,28,67], in juvenile schistosomes [68], and in P. falciparum, is clearly associated with
cytotoxicity. Overall, this study provides evidence that the interaction of endoperoxides with
neutral lipids may be an important component in their mechanism of action against malaria
parasites.
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Figure 1. Structure of ART and related compounds used in this study

Also shown are in vitro IC50 values (mean ± S.E.M.) for each compound, derived from three
independent P. falciparum growth assays.
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Figure 2. The fluorescent trioxane, 12C, accumulates in spherical structures closely associated with
the parasite DV

Trophozoite-stage cultures were treated with 1.0 μM 12C (top rows) or ART (bottom rows)
for 10 min prior to processing and microscopic visualization. A) Trophozoite-infected
erythrocytes. B) Saponin-released trophozoites. C. Isolated DV from a 12C-treated
trophozoite. Left panels show fluorescence, while right panels show fluorescence merged with
phase contrast. Parasites selectively accumulate 12C, which localizes within small (< 1 μm)
spheres adjacent to the parasite DV (white arrowheads). Scale bars represent 5 μm (A and B)
or 2 μM (C).
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Figure 3. 12C labels parasite NLB and surrounds merozoite membranes

NIH-PA Author Manuscript

A) Trophozoite-stage parasites were stained with the following probes: Lysosensor Green 189
for the DV (DV), DAPI for the nucleus (Nu), ERTracker Green for the endoplasmic reticulum
(ER), MitoTracker Red 580 for mitochondria (Mito), BODIPY 505/515 for neutral parasite
lipids (Lipid) or Nile Red for detection of NLB (NLB). Following incubation with probes,
cultures were exposed to 500 nM 12C for 10 min and processed for microscopic imaging.
Columns represent probe fluorescence (Probe), 12C fluorescence (12C) or combined
fluorescence of probe and 12C (Merge). Probes (except BODIPY 505/515 and Nile Red) were
pseudo-colored to emphasize differential staining compared with 12C signal. Micrographs
show merged fluorescence and phase contrast images of live trophozoite-infected erythrocytes
(DV and Nu) or saponin-released trophozoites. B) Merged images showing stage-specific
staining of live cells with the lipid probe Nile Red (30 nM), 12C (1 μM) or both applied
simultaneously. Nile Red exhibits an intense yellow-shifted fluorescence when incorporated
into neutral lipids (second row). In addition to NLB of trophozoites (Troph) and schizonts,
12C fluorescence surrounds merozoites within segmented schizonts (third and fourth row, far
right). Except for ring stages, parasites were released from erythrocytes by saponin treatment
prior to imaging. Scale bars represent 5 μm.
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Figure 4. ART inhibits NLB accumulation of 12C but cannot displace pre-loaded 12C
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A) From top to bottom, panels show parasites pre-treated with MeOH (0.01%), 500 nM dDHA
or ART prior to exposure to 500 nM 12C. Columns represent fluorescence (left) and
fluorescence merged with phase contrast (right). Prior to imaging, parasites were released from
erythrocytes by saponin treatment to increase accuracy of 12C signal intensity measurements.
B) Bar graph illustrating the mean volume of 12C fluorescence in NLB following pre-treatment
with MeOH (dark grey), dDHA (white) or ART (light grey). Values represent mean 12C signal
volume ± SEM, calculated from the average intensity (INT) and area (μm2) of signal from
labeled NLB. Means of 12C signal volume were derived from three independent experiments,
where each experiment is an average of 20-110 individual intensity measurements (see
Methods). Asterisk denotes significant difference (p < 0.01) between mean volume of ART
pre-treated samples and MeOH or dDHA controls. C) Localization of 12C (500 nM) within
NLB is not displaced by subsequent exposure to equimolar (top row) or excess (bottom row)
amounts of ART. Columns represent same view as described in A. Scale bars represent 5 μm.
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Figure 5. Localization of ART trioxane derivatives in NLB is endoperoxide dependent

NIH-PA Author Manuscript

A) Parasite cultures were treated with 500 nM ADD (top row), 500 nM dADD (middle row),
or both ADD and dADD at 500 nM each, applied simultaneously (bottom row). Images show
living, saponin-released trophozoites. Left panels show fluorescence, right panels are merged
images. Pseudocoloring was used to emphasize contrast in the differential distribution of each
drug. B) Mixed cultures of early and late segmenter-stage parasites were treated with 500 nM
ADD (top row) or 500 nM dADD (bottom row) for 30 min and imaged. For each stage, left
panels show fluorescence, right panels are merged images. C) Retention of ADD and dADD
in parasites following wash-out of drug. Following a 30 min exposure to 500 nM of either drug,
trophozoite-stage parasites were viewed 10 min (top row), 30 min (middle row), or 60 min
(bottom row) post-wash. For each drug, left panels show fluorescence, right panels are merged
images. D) Effect of thapsigargin (THP) and desferrioxamine (DFO) on localization of 12C.
From top to bottom, parasites were pre-treated for 10 min with MeOH or 500 nM THP, or for
1 h with 100 μM DFO, followed by exposure to 500 nM 12C (left column) or 30 nM Nile Red
(right column) for 10 min. All images show merged fluorescence with phase contrast. Scale
bars represent 5 μm.
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Figure 6. Exposure to ART results in formation of peroxyl radicals and alters parasite lipid
composition

A) Oxidation of BODIPY 581/591 C11 in ring, trophozoite (Troph) and segmenter-infected
cultures after 3.5 h exposure to MeOH (0.01%), or 250 nM ART, dDHA or mefloquine (MEF).
All panels show fluorescence merged with phase contrast. Only ART produces an emission
shift in BODIPY 581/591 C11, indicating the presence of peroxyl radicals in the parasite lipid
environment is endoperoxide dependent. Scale bars represent 5μm. B) Exposure to ART results
in modification of parasite lipids. Parasites were exposed to 1 μM of each drug for 5 h prior to
lipid extraction. Erythrocyte and parasitized-erythrocyte lipid extracts were separated by TLC
as described in Methods. i. Total lipid analysis of uninfected erythrocytes (lane 1); uninfected
erythrocytes incubated with ART (lane 2); parasitized-erythrocytes exposed to MEF (lane 3),
MeOH (lane 4), dDHA (lane 5) or ART (lane 6); lipid migration standard containing cholesteryl
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ester (CE), triacylglycerol (TAG), fatty acids (FA), cholesterol (CL), diacylglycerol (DAG),
phospholipids (PL) (lane 7). ART treatment (lane 6) results in an increase in FA content (bottom
red arrowhead), and a lipid species not observed in control treatments, with a similar mobility
to the CE standard (top red arrowhead). ii. Plates were derivatized with the LiebermannBurchard reagent for detection of CL and CE. In both the lipid standard (lane 8) and in the
ART-treated parasite lipid extracts (lane 9), derivatization results in a brown-violet CE band
(top black arrowhead) and a violet CL band (bottom black arrowhead). In i and ii, solvent front
was run to 0.5 cm from top of the plate, and background was eliminated to enhance contrast
of bands.
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